SURVIVAL OUTCOMES

May 28 2025SCIENCE

How Genes Shape Leukemia Outcomes

In the world of medicine, understanding how genes work is crucial. T-cell Acute Lymphoblastic Leukemia (T-ALL) is a type of blood cancer that affects children and young adults. Researchers looked into how a person's genetic background influences the disease and its treatment. Genetic background, or ancestry, plays a significant role in how T-ALL develops and respond...

reading time about 1 minute
May 22 2025HEALTH

How Money and Background Affect Stomach Cancer Treatment

The way people get treated for stomach cancer can be heavily influenced by their background. This isn't just about where they live or how much money they make. It's also about their education level, their job, and even their race. These factors can lead to delays in getting the right treatment. This can be a big deal because stomach cancer can be tough to beat. Ther...

reading time about 1 minute
May 12 2025HEALTH

The Impact of Durvalumab on Lung Cancer Patients with KRAS Mutations

Lung cancer is a complex disease. It is not one-size-fits-all. Stage III non-small cell lung cancer (NSCLC) is a prime example. It is a mixed bag of different subgroups. Some respond well to treatment. Others do not. This is why identifying these subgroups is so important. It helps doctors tailor treatments to each patient's needs. One treatment that has show...

reading time about 1 minute
Apr 25 2025HEALTH

The Impact of CAR-T Therapy on DLBCL Survival Rates

DLBCL is a type of blood cancer that can be tough to treat. It stands for diffuse large B-cell lymphoma. The introduction of CAR-T therapy has been a game-changer for patients with relapsed or refractory DLBCL. CAR-T therapy is a type of treatment that uses a patient's own immune cells to fight cancer. It was first approved by the FDA in 2017. But how has this ne...

reading time about 1 minute
Apr 22 2025HEALTH

The Power of Combining Drugs to Fight Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a type of breast cancer that lacks three specific receptors. This makes it tricky to treat. However, a recent study has shown some promising results. This study looked into how well a mix of two drugs, docetaxel and cisplatin, work together to fight TNBC. It was a phase II trial, which means it was a small-scale test to see i...

reading time about 2 minutes
Jan 11 2025HEALTH

Cancer Care Choices: Exploring Radiation Therapy for Elderly Patients

Imagine being told you have a type of skin cancer in your head or neck area that can't be removed by surgery. This is a tricky situation, especially if you're older or have other health issues. Doctors often turn to radiation therapy to control the cancer locally at the site. A recent study looked into how effective this treatment can be in terms of keeping the cance...

reading time about 1 minute
Jan 10 2025HEALTH

Fat Quality on X-Rays: Is It a Red Flag for Advanced Bile Duct Cancer?

Everyone knows cancer is scary. But did you know some patients with advanced bile duct cancer might have a special warning sign on their X-rays? This warning is all about fat. You might think fat is just fat, but scientists are finding out that the type of fat around your tummy can say a lot. When this fat shows up darker on X-rays, it could mean trouble for people w...

reading time about 1 minute
Dec 22 2024HEALTH

The HER2 Factor: How It Affects TNBC Patients on Capecitabine

Triple-negative breast cancer (TNBC) is a tough nut to crack. When patients receive adjuvant capecitabine, doctors aren't quite sure how the HER2 protein will impact their survival. Let's dive into this puzzle. First, what's HER2? It's a protein that can sometimes go into overdrive in breast cancer cells. In TNBC, things get complicated because HER2 isn't usually th...

reading time about 1 minute
Dec 09 2024HEALTH

Understanding KRAS in Biliary Tract Cancers: A Survival Study

Scientists have been looking into the role of KRAS variants in biliary tract cancers. These cancers include intrahepatic cholangiocarcinoma (IHC), extrahepatic cholangiocarcinoma (EHC), and gallbladder adenocarcinoma (GB). The study aimed to find out how common these KRAS variants are and if they affect how long patients live or if the cancer comes back. Biliary tra...

reading time less than a minute